Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Impact on Dyskinesia
Objective: Assess impact of apomorphine sublingual film (APL-130277; APL) on time spent with and functional impact of dyskinesia among patients with Parkinson’s disease (PD) and…Real Time Quality Control for Subjective Endpoints in Clinical Trials
Objective: Here we present a system which is capable of performing nearly-real time monitoring of UPDRS part-3 motor assessments using a combination of multidimensional statistics…On-Demand Treatment Preferences of Patients with Parkinson’s Disease and “OFF” Episodes: Heterogeneity Across Patient Subgroups
Objective: To quantify preference heterogeneity for on-demand treatments among patients with Parkinson’s disease (PD) and “OFF” episodes. Background: Patients with PD commonly experience “OFF” episodes.…Correlation between location of active contacts and weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease
Objective: Objective: The aim of this study was to evaluate the correlation between the location of active contacts and weight gain after subthalamic nucleus deep…All-cause mortality in pimavanserin and atypical antipsychotic users with Parkinson’s disease in Medicare
Objective: To assess all-cause mortality in Medicare beneficiaries with Parkinson’s disease (PD) receiving pimavanserin or atypical antipsychotics (AAs). Background: In PD patients, the lifetime prevalence…Towards a scoring system to distinguish early parkinsonian variant of multiple system atrophy from Parkinson’s disease
Objective: To develop a clinical score to distinguish between the parkinsonian variant of multiple system atrophy (MSA-P) and Parkinson’s disease (PD). Background: The differential diagnosis…Vascular parkinsonism and Parkinson’s disease: Differences concerning performance in activities of daily living
Objective: Determine and compare performance in activities of daily living between vascular parkinsonism (VP) and Parkinson’s disease (PD) patients in a hospital-based sample. Background: Despite…Demonstrating the clinical value of MANAGE-PD tool in assessing symptom control of Parkinson’s disease patients: Evidence from G7 countries
Objective: Evaluate the clinical value of using MANAGE-PD tool for assessing PD symptom control in real-world setting. Background: MANAGE-PD is a validated [1], web-based tool…Cognitive and psychiatric symptoms are associated with walking difficulties in mild Parkinson’s disease
Objective: To investigate the association of different aspects of cognitive impairment, depression and anxiety with walking difficulties in daily life in persons with mild PD.…Comparative analysis of the quality of life between healthy elderly people and those with Parkinson’s disease
Objective: To compare the impact of PD on the quality of life and functioning of the elderly with and without PD. Background: Parkinson's disease (PD)…
- « Previous Page
- 1
- …
- 90
- 91
- 92
- 93
- 94
- …
- 388
- Next Page »